Oncotelic Advances PLA from Published Liver Cancer Findings Toward 100 Billion Protein Vectors
PLA gives overlooked biological evidence its own analysis before combining the findings. Published HCC research connects PLA-guided investigation with a four-gene survival signature validated in an independent patient cohort. As Anthropic and OpenAI expand biological discovery with AI agents, Oncotelic is targeting a 100-billion-vector protein program. Oncotelic Therapeutics Inc. (OTCQB: OTLC) is building its PDAOAI drug discovery engine around a compelling premise: a clue buried in a small corner of the literature can redirect an entire research program. Its Partitioned Literature Aggregation (“PLA”) algorithm is designed to uncover those clues. A liver-cancer study published in Biomedicines on October 23, 2026,…